Papers matching “post-transplant maintenance” 20
Not finding it? Sign in to also search OpenAlex live.
-
Conversion from Calcineurin Inhibitor– to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial2021 Journal of the American Society of Nephrology article Medicine Renal Transplantation Outcomes and Treatments Open access
Klemens Budde, Rohini Prashar, Hermann G. Haller, Maria C. Rial, Nassim Kamar, Avinash Kumar Ágarwal, +9 more
105citations -
Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia Report
Pedro Henrique Prata, Dirk‐Jan Eikema, Brian Piepenbroek, Austin Gladston Kulasekararaj, Beatrice Drexler, Jennifer M.L. Tjon, +19 more
1citations -
Daratumumab (DARA) Plus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Patients with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of Griffin after 12 Months of Maintenance Therapy
Jonathan L. Kaufman, Jacob P. Laubach, Douglas Weston Sborov, Brandi Reeves, Cesar Rodriguez, Ajai Chari, +21 more
24citations -
Daratumumab (DARA) with Bortezomib, Thalidomide, and Dexamethasone (VTd) in Transplant-Eligible Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM): Analysis of Minimal Residual Disease (MRD) Negativity in Cassiopeia Part 1 and Part 2
Hervé Avet‐Loiseau, Pieter Sonneveld, Philippe Moreau, Fritz C. Offner, Vincent H. J. van der Velden, Denis Caillot, +25 more
21citations -
Pediatric Lung Transplant Outcomes Based on Immunosuppressive Regimen at Discharge: Retrospective Cohort Study Using Real-World Evidence From the US Scientific Registry of Transplant Recipients
Jay Erdman, Josephine Wolfram, David Nimke, Richard Croy, Xuegong Wang, Tim A. Weaver, +2 more
4citations -
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS‐like tyrosine kinase 3 ( FLT3 )‐mutated acute myeloid leukaemia patients: A multicentre real‐world study
Desireé Kunadt, Sven Zukunft, Christoph Röllig, Stephan Metzelder, Andreas Burchert, Eva Wagner‐Drouet, +50 more
0citations -
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial2024 Journal of Clinical Oncology article Medicine Multiple Myeloma Research and Treatments Open access
Elias Karl Mai, Uta Bertsch, Ema Požek, Roland R. Fenk, Britta Besemer, Christine Hanoun, +71 more
80citations -
Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment2022 Transplantation and Cellular Therapy article Medicine Multiple Myeloma Research and Treatments Open access
Marta Reinoso‐Segura, Teresa Caballero‐Velázquez, Pilar Herrera, Francesca F. Patriarca, Renato Fanin, Benedetto Bruno, +8 more
7citations -
Transplant Outcomes for Acute Myeloid Leukemia or Myelodysplastic Syndromes Secondary to Acquired Aplastic Anemia or Paroxysmal Nocturnal Hemoglobinuria: A Report from the EBMT Severe Aplastic Anemia Working Party
Pedro Henrique Prata, Dirk‐Jan Eikema, Brian Piepenbroek, Austin Gladston Kulasekararaj, Beatrice Drexler, Jennifer M.L. Tjon, +19 more
2citations -
Alveolar macrophage activation and polarization signatures in stable lung transplant recipients and chronic lung allograft dysfunction2026 The Journal of Heart and Lung Transplantation article Medicine Transplantation: Methods and Outcomes Open access
Edith Katharina Plucinski, Jan C. Kamp, Svenja Gaedcke, Christopher Werlein, Stephanie Schubert, Da‐Hee Park, +11 more
2citations
20 results